✦ LIBER ✦

The relationship between progression-free and post-progression survival in treating four types of metastatic cancer

✍ Scribed by Russell J. Bowater; Luke J. Bridge; Richard J. Lilford

Book ID: 116334606
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 109 KB
Volume: 262
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2007.11.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A systematic review evaluating the relat

A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer

✍ Sudha Sundar; Jianhua Wu; Kathryn Hillaby; Jason Yap; Richard Lilford 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 523 KB

Meta-analysis of the association between

Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer

✍ Costel Chirila; Dawn Odom; Giovanna Devercelli; Shahnaz Khan; Bintu N. Sherif; J 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 367 KB

Association between VEGF Splice Isoforms

Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab

✍ Bates, D. O.; Catalano, P. J.; Symonds, K. E.; Varey, A. H. R.; Ramani, P.; O'Dw 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 834 KB

Relationship between effects on time-to-

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

✍ Sherrill, B; Amonkar, M; Wu, Y; Hirst, C; Stein, S; Walker, M; Cuzick, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

POD-6.12: Progression Free Survival in P

POD-6.12: Progression Free Survival in Patients with Metastatic and Recurrent Renal Cancer Treated with Sorafenib: Single Center Experience

✍ A. Kapoor; S. Chatterjee; J. Pinthus; S. Hotte; N. Kleinmann 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Relationship between ornithine decarboxy

Relationship between ornithine decarboxylase levels in anaplastic gliomas and progression-free survival in patients treated with DFMO–PCV chemotherapy

✍ Victor A. Levin; Jacob L. Jochec; Lisa M. Shantz; Kenneth D. Aldape 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB

## Abstract The purpose of this study was to assess the relationship between progression‐free survival (PFS) in patients treated with DFMO + PCV (procarbazine, CCNU, vincristine) chemotherapy for malignant gliomas with tumor cell ornithine decarboxylase (ODC) activity. Formalin‐fixed slides were ob